These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 12873136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry.
    Kingsbury JS, Théberge R, Karbassi JA, Lim A, Costello CE, Connors LH.
    Anal Chem; 2007 Mar 01; 79(5):1990-8. PubMed ID: 17261023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y, Ueda M, Fujimori H, Shinriki S, Meng W, Kim J, Saito S, Obayashi K, Uchino M, Ando Y.
    Amyloid; 2008 Dec 01; 15(4):234-9. PubMed ID: 19065294
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The pathway by which the tetrameric protein transthyretin dissociates.
    Foss TR, Wiseman RL, Kelly JW.
    Biochemistry; 2005 Nov 29; 44(47):15525-33. PubMed ID: 16300401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
    Saito S, Ando Y, Nakamura M, Ueda M, Kim J, Ishima Y, Akaike T, Otagiri M.
    Biochemistry; 2005 Aug 23; 44(33):11122-9. PubMed ID: 16101296
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
    Palaninathan SK, Mohamedmohaideen NN, Snee WC, Kelly JW, Sacchettini JC.
    J Mol Biol; 2008 Oct 24; 382(5):1157-67. PubMed ID: 18662699
    [Abstract] [Full Text] [Related]

  • 15. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y, Ore MO, Morin S, Wilson DJ.
    Biochemistry; 2012 Apr 24; 51(16):3523-30. PubMed ID: 22482799
    [Abstract] [Full Text] [Related]

  • 16. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
    Hurshman AR, White JT, Powers ET, Kelly JW.
    Biochemistry; 2004 Jun 15; 43(23):7365-81. PubMed ID: 15182180
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
    Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW.
    Amyloid; 2006 Jun 15; 13(2):57-66. PubMed ID: 16911959
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA, Lai Z, Kelly JW.
    Biochemistry; 1998 Dec 22; 37(51):17851-64. PubMed ID: 9922152
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
    Raghu P, Reddy GB, Sivakumar B.
    Arch Biochem Biophys; 2002 Apr 01; 400(1):43-7. PubMed ID: 11913969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.